Raymond John Andersen

USPTO Granted Patents = 42 (Patent Applications = 23)

CIPO Patents = 9 (Patent Applications = 7)

EPO Patents = 14 (Patent Applications = 18)

Average Co-Inventor Count = 4.9

ph-index = 12

Forward Citations = 276(Granted Patents)

Company Filing History:

33 out of 932

The University of British Columbia

patents

14 out of 61

British Columbia Cancer Agency Branch

patents

5 out of 446

University of Alberta

patents

4. 5 out of 23

Provincial Health Services Authority

Cornell Research Foundation Inc.

patents

9. 3 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2024

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Androgen Receptor Modulators

Heterocyclic Compounds

Cancer Imaging

MHC-I Expression

Bisphenol Derivatives

Glucosidase Inhibitors

Biologically Active Peptides

Antimitotic Compounds

Cyclic Decapeptide Antibiotics

Small Molecule Inhibitors

SHIP1 Modulators

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109179 - Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof (2024-10-08),

2. 12011421 - Curcuphenol compounds for increasing MHC-I expression (2024-06-18),

3. 11919874 - Bisphenol derivatives and their use as androgen receptor activity modulators (2024-03-05),

4. 11779550 - Bisphenol ether derivatives and methods for using the same (2023-10-10),

5. 11485713 - Androgen receptor modulators and methods for their use (2022-11-01),

6. 11345670 - Heterocyclic compounds for cancer imaging and treatment and methods for their use (2022-05-31),

7. 11197832 - Curcuphenol compounds for increasing MHC-I expression (2021-12-14),

8. 11142508 - Bisphenol derivatives and their use as androgen receptor activity modulators (2021-10-12),

9. 11059795 - Androgen receptor modulators and methods for their use (2021-07-13),

10. 10751296 - Curcuphenol compounds for increasing MHC-I expression (2020-08-25),

11. 10654811 - Heterocyclic compounds for cancer imaging and treatment and methods for their use (2020-05-19),

12. 10583167 - Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof (2020-03-10),

13. 10471023 - Bisphenol ether derivatives and methods for using the same (2019-11-12),

14. 10071962 - Androgen receptor modulators and methods for their use (2018-09-11),

15. 9862667 - Diglycidic ether derivative therapeutics and methods for their use (2018-01-09),

Title: Raymond John Andersen: Pioneering Innovations in Cancer Research

Introduction:

Raymond John Andersen, a distinguished inventor hailing from Vancouver, CA, has made significant contributions to the field of pharmaceuticals and cancer research. With an impressive portfolio of 40 patents, Andersen's work has been instrumental in developing novel compounds for therapeutic use.

Latest Patents:

1. "Bisphenol derivatives and their use as androgen receptor activity modulators": This patent focuses on compounds that modulate androgen receptor activity, with applications in cancer diagnostics and therapeutics.

2. "Bisphenol ether derivatives and methods for using the same": This patent centers on compounds used for modulating androgen receptor activity, particularly in the treatment of prostate cancer.

Career Highlights:

Andersen has left a lasting impact through his work at the University of British Columbia and the British Columbia Cancer Agency Branch. His dedication to advancing medical science and improving patient outcomes is evident in the groundbreaking patents he has secured.

Collaborations:

Throughout his career, Andersen has collaborated with esteemed professionals in the field. Notable coworkers include Marianne Dorothy Sadar and Nasrin R Mawji, whose expertise has complemented Andersen's innovative approach to research and development.

Conclusion:

Raymond John Andersen's unwavering commitment to innovation in cancer therapeutics has solidified his reputation as a trailblazer in the field. His patents not only showcase his technical prowess but also reflect his enduring impact on the medical community. Andersen's groundbreaking work serves as a testament to the power of research and dedication in advancing healthcare solutions for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.